¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY2) : 2022-10-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY2) : 2022-10-06
±³À°ÀÏÀÚ : 2022-10-06
±³À°Àå¼Ò : ¼­¿ï COEX Room A(102+103È£)  
±³À°ÁÖÁ¦ : Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY2)
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190  
À̸ÞÀÏ : urology@urology.or.kr      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 900¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 110,000¿ø      
ºñ°í #»çÀüµî·Ï ±âÁØ Àü¹®ÀÇ: 110,000¿ø Àü°øÀÇ: 77,000¿ø Çлý, ÀÎÅÏ: 55,000¿ø °£È£»ç, ¿¬±¸¿ø: 66,000¿ø Á¦¾àȸ»ç ¹× ÀÇ·á±â±âȸ»ç: 132,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-06 Room A (102+103È£) 09:30~09:45 Daily highlight  ÃÖÀç´ö(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 09:45~10:00 Voiding dysfunction X female urology  Priya Padmanabhan(Beaumont Hospital) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 10:00~10:15 Prostate MRI fusion Biopsy technology made it easy  Fernando Kim(Denver Health Medical Center) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 10:15~10:30 From precision medicine to precision surgery: how to use medical technology to improve oncology outcome  Arnulf Stenzl(University of Tübingen Medical Center) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 10:30~10:45 Robotic assisted Laparoscopic repair of Vesico-vaginal fistula  Noor Ashani Md Yusoff(Hospital Kuala Lumpur) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 10:45~11:00 Does really differences exist in prostate cancer biology between Korean versus Western counterparts.  È«¼º±Ô(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 11:00~11:15 Postprostatectomy incontinence - Revisit of cystography  Chun-Te Wu(Chang Gung Memorial Hospital) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 11:15~11:30 Current topics for urothelial cancer in Japan 2022  Hiroyuki Nishiyama(Tsukuba University) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 11:30~11:45 Preferences of patients with LUTS/BPO and treatment selection  Stavros Gravas(Univesity of Cyprus) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 11:45~12:00 Immunotherapy for Prostate Cancer - Hope or Hype?  Christian Gratzke(Albert-Ludwigs-University Freiburg) 
½Ä»ç 10-06 Room A (102+103È£) 12:00~13:00 Á¡½É½Ä»ç  () 
±³À°½Ã°£ 10-06 Room A (102+103È£) 13:00~13:30 Medical Metaverse  ¹Ú»óÁØ(¸ÞµðÄþÆÀÌÇÇ) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 13:30~14:00 Digital Healthcare 2022  ³ª±ºÈ£(³×À̹ö ÇコÄɾî) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 14:00~14:30 Cryptocurrency based Web 3.0 and Medical AI  ·ùÁ¤¿ø(Èú¼¼¸®¿Â) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 14:30~15:00 Modernization of Japan and the role of doctors  ½Å»ó¸ñ(±â¸®¾ß¸¶º»Áø) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 15:00~15:15 How to interpret PHI  ±èÁ¤Çö(°­¿øÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 15:15~15:30 Perioperative chemotherapy for upper tract urothelial cancer: Show me the evidence!  Á¤º´Ã¢(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 15:30~15:45 Oligometastatic urothelial carcinoma-when to consider curative intent treatment?  ¹Ú½Âö(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 15:45~16:00 Oncologic benefit of postchemotherapy RPLND in metastatic testicular cancers.  Á¤Ã¢¿í(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 16:00~16:15 Debate 1: Is penile rehabilitation still worthwhile for treating erectile dysfunction? - Pros  ¾È¼øÅÂ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 16:15~16:30 Debate 1: Is penile rehabilitation still worthwhile for treating erectile dysfunction? - Cons  °¨¼ºÃ¶(°æ»óÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 16:30~16:45 Debate 2: Huge BPH: Robot-assisted simple prostatectomy vs. Transurethral enucleation (HoLEP, BipoLEP, etc) - Robot-assisted  ½ÅÀ¯¼·(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 16:45~17:00 Debate 2: Huge BPH: Robot-assisted simple prostatectomy vs. Transurethral enucleation (HoLEP, BipoLEP, etc) - HoLEP  ±èÇö¿ì(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 17:00~17:15 Debate 3: Can the active surveillance protocol from Western country applied to Korean patients? - Pros  ±èº´ÈÆ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 10-06 Room A (102+103È£) 17:15~17:30 Debate 3: Can the active surveillance protocol from Western country applied to Korean patients? - Cons  ÇÏÈ«±¸(ºÎ»êÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY2) : 2022-10-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æºÏ´ëÇб³ ¾È°úÇб³½Ç ¸ñ¿ä Áý´ãȸ : 2022-10-06
´ÙÀ½±Û ¼­¿ï´ëÇб³º´¿ø 2022³â Á¦3Â÷ ¾Æµ¿Çдë Àü´ãÀÇ·á±â°ü ¿ª·®°­È­ ¿öÅ©¼ó : 2022-10-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21003 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú (¿Â¶óÀÎ) 29th Vestibular Function Test Workshop : 2024-06-23 0 13 2024-06-17
21002 ¼­¿ï ´ëÇѳëÀο©¼ºÀÇÇÐȸ Á¦33Â÷ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-06-23 0 25 2024-06-17
21001 ¼­¿ï ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦5ȸ ½ÉÈ­ ½ÉÆ÷Áö¾ö : 2024-06-23 0 10 2024-06-17
21000 ºÎ»ê ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦19Â÷ Çмú´ëȸ : 2024-06-23 0 14 2024-06-17
20999 ¼­¿ï 2024³â 6¿ù ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 18 2024-06-17
20998 ¼­¿ï Á¦ 10ȸ ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 27 2024-06-17
20997 ¼­¿ï ´ëÇѵÎÅëÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-06-23 0 24 2024-06-17
20996 ´ë±¸ 2024³â ´ëÇѼÒÈ­±âÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 18 2024-06-17
20995 °æ±â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °æÀÎÁöȸ Á¦7ȸ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-23 0 59 2024-06-16
20994 ¼­¿ï Á¦18ȸ ´ëÇѺñ°úÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-23 0 29 2024-06-16
20993 ÀÎõ ÀÎÇÏ´ëÇб³º´¿ø Á¦6ȸ ÀÎÇÏÇǺνÉÆ÷Áö¾ö : 2024-06-22 0 16 2024-06-16
20992 ¼­¿ï Á¦23ȸ Çѱ¹Á¤¸Æ°æÀ念¾çÇÐȸ Çмú´ëȸ ¹× 2024 ±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-22 0 27 2024-06-16
20991 ¼­¿ï 2024³â Á¦2Â÷ ´ëÇѳëÀÎÀÇÇÐ ¼¼ºÎÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-22 0 21 2024-06-16
20990 ¼­¿ï ´ëÇѼҾÆÀçÈ°¹ß´ÞÀÇÇÐȸ Çмú´ëȸ : 2024-06-22 0 16 2024-06-16
20989 °æ±â 2024³â ¾È¾ç½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 8 2024-06-16
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷